Skip to content
Storytelling Co – Lifestyle
Author:
Deep Origin
Drug Developers Deploy In Silico Drug Safety Prediction Models From Deep Origin’s ARPA-H-Funded PREDICTS Consortium
September 24, 2026
Deep Origin Introduces Novel Virtual Screening Architecture; Achieves 100-fold Hit Rate Jump on Challenging Target
August 5, 2026
Deep Origin’s Computational Platform Rationalizes Results of Molecular Glue Compound That Potently Kills Diffuse Large B Cell Lymphoma Cells
July 20, 2026
Tim Foley Joins Deep Origin as Chief Commercial Officer
March 31, 2026